News & Updates

Show Multimedia Only
Statins show therapeutic potential in COVID-19-related acute kidney injury

Statins show therapeutic potential in COVID-19-related acute kidney injury

26 Oct 2022 byJairia Dela Cruz

COVID-19 patients with chronic statin exposure appear to be at lower risk of developing acute kidney injury (AKI) during hospitalization in addition to having reduced levels of inflammation, as reported in a study.

26 Oct 2022
Cefepime-taniborbactam trumps meropenem for complicated UTI Cefepime-taniborbactam trumps meropenem for complicated UTI

Cefepime-taniborbactam trumps meropenem for complicated UTI

26 Oct 2022 byTristan Manalac

Cefepime-taniborbactam (FTB) is significantly better than meropenem for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP), according to results of the Cefepime Rescue with Taniborbactam in cUTI (CERTAIN-1) study presented at the recent ID Week 2022.

26 Oct 2022